PUBLISHER: TechNavio | PRODUCT CODE: 2126174
PUBLISHER: TechNavio | PRODUCT CODE: 2126174
Global Clinical Trial Imaging Market 2026-2030
The global clinical trial imaging market is forecasted to grow by USD 628.5 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global clinical trial imaging market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in chronic diseases and growing demand for precision medicine, technological advancements in imaging modalities and ai integration, increasing outsourcing of clinical trial operations to specialized imaging core laboratories.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.3% |
| CAGR | 7.5% |
| Incremental Value | $628.5 mn |
Technavio's global clinical trial imaging market is segmented as below:
By Modality
- Computed tomography
- Magnetic resonance imaging
- Ultrasound
- Positron emission tomography
- Others
By End-User
- Contract research organization
- Pharmaceutical companies
- Research and academic institutes
- Medical device manufacturers
By Application
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the evolution of decentralized and hybrid clinical trial models as one of the prime reasons driving the global clinical trial imaging market growth during the next few years. Also, integration of radiomics and quantitative imaging biomarkers and advancements in cloud-native platforms and automated data workflows will lead to sizable demand in the market.
The report on the global clinical trial imaging market covers the following areas:
- Global clinical trial imaging market sizing
- Global clinical trial imaging market forecast
- Global clinical trial imaging market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global clinical trial imaging market vendors that include Banook Group, Circle Cardiovascular Imaging, Clario, Fortrea Holdings Inc., IA Group, ICON plc, IQVIA Holdings Inc., IXICO plc, Median Technologies SA, Medpace Holdings Inc., Micron Oncology CRO, Perceptive Informatics, PPD, Prism Clinical Research, ProScan Imaging, Radiant Sage, Resonance Health, Syneos Health Inc., Voiant, WCG Clinical Inc.. Also, the global clinical trial imaging market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Modality
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Clinical Trial Imaging Market 2020 - 2024
- Historic Market Size - Data Table on Global Clinical Trial Imaging Market 2020 - 2024 ($ million)
- 5.2 Modality segment analysis 2020 - 2024
- Historic Market Size - Modality Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Clinical Trial Imaging Market
- 6.2 Impact of Geopolitical Conflicts on Global Clinical Trial Imaging Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Modality
- 8.1 Market segments
- 8.2 Comparison by Modality
- 8.3 Computed tomography - Market size and forecast 2025-2030
- 8.4 Magnetic resonance imaging - Market size and forecast 2025-2030
- 8.5 Ultrasound - Market size and forecast 2025-2030
- 8.6 Positron emission tomography - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Modality
- Market opportunity by Modality ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Contract research organization - Market size and forecast 2025-2030
- 9.4 Pharmaceutical companies - Market size and forecast 2025-2030
- 9.5 Research and academic institutes - Market size and forecast 2025-2030
- 9.6 Medical device manufacturers - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Oncology - Market size and forecast 2025-2030
- 10.4 Neurology - Market size and forecast 2025-2030
- 10.5 Cardiology - Market size and forecast 2025-2030
- 10.6 Endocrinology - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 South Korea - Market size and forecast 2025-2030
- 12.5.4 India - Market size and forecast 2025-2030
- 12.5.5 Taiwan - Market size and forecast 2025-2030
- 12.5.6 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 Israel - Market size and forecast 2025-2030
- 12.6.7 Egypt - Market size and forecast 2025-2030
- 12.6.8 Chile - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rise in chronic diseases and growing demand for precision medicine
- Technological advancements in imaging modalities and AI integration
- Increasing outsourcing of clinical trial operations to specialized imaging core laboratories
- 13.2 Market challenges
- High capital investment and operational expenditure
- Technical variability and lack of standardization across multi-center studies
- Data security vulnerabilities and complex regulatory compliance demands
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Evolution of decentralized and hybrid clinical trial models
- Integration of radiomics and quantitative imaging biomarkers
- Advancements in cloud-native platforms and automated data workflows
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Fortrea Holdings Inc.
- Fortrea Holdings Inc. - Overview
- Fortrea Holdings Inc. - Product / Service
- Fortrea Holdings Inc. - Key offerings
- SWOT
- 15.5 IA Group
- IA Group - Overview
- IA Group - Product / Service
- IA Group - Key offerings
- SWOT
- 15.6 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 15.7 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 15.8 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
- 15.9 Micron Oncology CRO
- Micron Oncology CRO - Overview
- Micron Oncology CRO - Product / Service
- Micron Oncology CRO - Key offerings
- SWOT
- 15.10 Perceptive Informatics
- Perceptive Informatics - Overview
- Perceptive Informatics - Product / Service
- Perceptive Informatics - Key offerings
- SWOT
- 15.11 PPD
- PPD - Overview
- PPD - Product / Service
- PPD - Key offerings
- SWOT
- 15.12 Prism Clinical Research
- Prism Clinical Research - Overview
- Prism Clinical Research - Product / Service
- Prism Clinical Research - Key offerings
- SWOT
- 15.13 ProScan Imaging
- ProScan Imaging - Overview
- ProScan Imaging - Product / Service
- ProScan Imaging - Key offerings
- SWOT
- 15.14 Radiant Sage
- Radiant Sage - Overview
- Radiant Sage - Product / Service
- Radiant Sage - Key offerings
- SWOT
- 15.15 Resonance Health
- Resonance Health - Overview
- Resonance Health - Product / Service
- Resonance Health - Key offerings
- SWOT
- 15.16 Syneos Health Inc.
- Syneos Health Inc. - Overview
- Syneos Health Inc. - Product / Service
- Syneos Health Inc. - Key offerings
- SWOT
- 15.17 Voiant
- Voiant - Overview
- Voiant - Product / Service
- Voiant - Key offerings
- SWOT
- 15.18 WCG Clinical Inc.
- WCG Clinical Inc. - Overview
- WCG Clinical Inc. - Product / Service
- WCG Clinical Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
